Chemotherapy compound chemical mix
Ended Blanket Purchase Agreement Awarded Last action
- Contract number
- 36C24221A0040
- Awardee
-
Optum Infusion Services 308, LLC UEI RN5UVE9XMJN4 Part of Unitedhealth Group Incorporated
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 5 $135,286 obligated
Award facts
- Opportunity
-
- 36C24221Q1236 Solicitation number
- Combined order value
- $235,000 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 27% used
- $500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, holds a single-award Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs Veterans Integrated Service Network 2 (VISN 2) for the provision of chemotherapy compound chemical mixes. The agreement, valued at $500,000, was awarded on August 24, 2021, with an ultimate completion date of August 23, 2026. The contract employs a firm fixed-price pricing structure with no set-aside designation, indicating full and open competition. Services are performed at the contractor's Phoenix, Arizona facility, supporting the pharmaceutical compounding needs of the VA healthcare system within VISN 2. The scope encompasses the preparation and delivery of customized chemotherapy compounds necessary to support cancer treatment programs and oncology medication services delivered to veterans across the network.
The BPA has been exercised through multiple task order awards spanning the contract period, with documented calls issued annually. These task orders include a base-year award (August 2021-August 2022), a renewal option year one (August 2022-August 2023), option year two with a $100,000 ceiling (August 2023-August 2024), option year three with a $135,000 ceiling (August 2024-August 2025), and option year four with a $100,000 ceiling (August 2025-August 2026). The contractor maintains compliance with Federal Drug Administration 503A pharmaceutical drug compounding standards and United States Pharmacopeia standards 797, 795, and 800 for hazardous drug preparation. All task orders have been awarded without set-aside designations on a firm fixed-price basis, demonstrating the government's reliance on the contractor's specialized capabilities in oncology pharmaceutical compounding to support VA medical center operations.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Novation Agreement | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C24221A0040?
36C24221A0040 was awarded to Optum Infusion Services 308, LLC by Veterans Integrated Service Network 2 (Veterans Health Administration) on August 24, 2021.
How much is contract 36C24221A0040 worth?
Orders under 36C24221A0040 have obligated $135,286. Their combined current value, with exercised options, is $235,000. 36C24221A0040's own ceiling is $500,000.
How many orders have been placed under contract 36C24221A0040?
5 orders have been placed under 36C24221A0040, the latest on August 24, 2025.
Who can order from contract 36C24221A0040?
36C24221A0040 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV